jilibay slot

COPENHAGEN, Denmark, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the U.S. Food & Drug Administration (FDA) has accepted for review its supplemental Biologics License Application (sBLA) in adult growth hormone deficiency (GHD) for TransCon hGH (lonapegsomatropin-tcgd; marketed as SKYTROFA® for pediatric GHD). The FDA set a Prescription Drug User Fee Act (PDUFA) goal date of July 27, 2025. “This marks another step towards achieving our objective to expand SKYTROFA’s label beyond pediatric GHD and expand its reach to address new groups of patients,” said Jan Mikkelsen, Ascendis Pharma’s President and Chief Executive Officer. “Adult GHD is an undertreated condition associated with significant comorbidities and higher annual healthcare costs compared to the 5-10% of patients who receive treatment, indicative of the high unmet need.” The sBLA submission is based on results from foresiGHt, a Phase 3 randomized, parallel-arm, placebo-controlled (double-blind) and active-controlled (open-label) trial that compared the efficacy and safety of weekly TransCon hGH with weekly placebo and daily human growth hormone (hGH) in adults with GHD. The trial evaluated 259 adults with GHD aged 23 to 80 years old, randomized 1:1:1, titrated to receive a target fixed dose of TransCon hGH, placebo, or daily hGH based on age and oral estrogen intake with approximately equivalent hGH mg/week for TransCon hGH and daily hGH. TransCon hGH demonstrated superiority on its primary efficacy and key secondary efficacy endpoints at Week 38, with TransCon hGH-treated participants showing a statistically significant reduction from baseline in trunk fat and increase in total body lean mass at Week 38 compared to placebo. In the trial, TransCon hGH was generally safe and well tolerated, with no discontinuations related to study drug and with comparable safety and tolerability to daily hGH treatment. About Adult Growth Hormone Deficiency Growth hormone plays an essential role in the health of children and adults, promoting normal growth in children and maintenance of normal body composition and cardiometabolic health throughout adulthood. In adults, growth hormone boosts protein production, promotes fat utilization, enhances muscle mass, and helps regulate blood sugar levels. Adult GHD is a condition in which an individual’s body does not produce enough growth hormone. Symptoms and morbidity can include central obesity, metabolic syndrome, decreased bone density, alterations in lipid profile and markers of cardiovascular risk, fatigue, general weakness, lack of muscle tone, and psychological symptoms such as cognitive impairment, social isolation, lack of motivation, and depression.1 About Ascendis Pharma A/S Ascendis Pharma is applying its innovative TransCon technology platform to build a leading, fully integrated biopharma company focused on making a meaningful difference in patients’ lives. Guided by its core values of Patients, Science, and Passion, Ascendis uses its TransCon technologies to create new and potentially best-in-class therapies. Ascendis is headquartered in Copenhagen, Denmark and has additional facilities in Europe and the United States. Please visit ascendispharma.com to learn more. Forward-Looking Statements This press release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this press release regarding Ascendis’ future operations, plans and objectives of management are forward-looking statements. Examples of such statements include, but are not limited to, statements relating to (i) the PDUFA goal date for SKYTROFA, (ii) Ascendis’ objective to expand SKYTROFA’s label and reach to address new groups of patients, (iii) Ascendis’ ability to apply its TransCon technology platform to build a leading, fully integrated biopharma company, and (iv) Ascendis’ use of its TransCon technologies to create new and potentially best-in-class therapies. Ascendis may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in the forward-looking statements and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions, expectations, and projections disclosed in the forward-looking statements. Various important factors could cause actual results or events to differ materially from the forward-looking statements that Ascendis makes, including the following: dependence on third party manufacturers, distributors and service providers for Ascendis’ products and product candidates; unforeseen safety or efficacy results in Ascendis’ development programs or on-market products; unforeseen expenses related to commercialization of any approved Ascendis products; unforeseen expenses related to Ascendis’ development programs; unforeseen selling, general and administrative expenses, other research and development expenses and Ascendis’ business generally; delays in the development of its programs related to manufacturing, regulatory requirements, speed of patient recruitment or other unforeseen delays; Ascendis’ ability to obtain additional funding, if needed, to support its business activities; the impact of international economic, political, legal, compliance, social and business factors. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to Ascendis’ business in general, see Ascendis’ prospectus supplement filed on September 20, 2024 and Ascendis’ current and future reports filed with, or submitted to, the U.S. Securities and Exchange Commission (SEC), including its Annual Report on Form 20-F filed with the SEC on February 7, 2024. Forward-looking statements do not reflect the potential impact of any future licensing, collaborations, acquisitions, mergers, dispositions, joint ventures, or investments that Ascendis may enter into or make. Ascendis does not assume any obligation to update any forward-looking statements, except as required by law. Ascendis, Ascendis Pharma, the Ascendis Pharma logo, the company logo, TransCon, and SKYTROFA ® , are trademarks owned by the Ascendis Pharma group. © December 2024 Ascendis Pharma A/S. 1.Hoffman AR, Mathison T, Andrews D, Murray K, Kelepouris N, Fleseriu M. Adult Growth Hormone Deficiency: Diagnostic and Treatment Journeys From the Patients' Perspective. J Endocr Soc. 2022;6(7):bvac077. Published 2022 May 12. doi:10.1210/jendso/bvac077NFL ends investigation into sexual assault allegations against Browns QB Deshaun WatsonThe Albanese government will probe whether Meta has unlawfully promoted scams on its platforms, as the social media giant continues to take advertising money from criminals pushing blatantly fraudulent schemes on Facebook that target vulnerable Australians. Financial Services Minister Stephen Jones said he had asked his department and office to examine whether Meta was breaching existing laws, including its criminal and civil obligations. Assistant Treasurer Stephen Jones wants to examine if Meta has broken laws. Credit: Dominic Lorrimer “Every hour that a scam ad is live on a Meta platform causes harm,” Jones said. “It’s not good enough that they don’t have a system which enables blatantly criminal material to be removed.” Jones’ comments came after this masthead published an investigation showing Meta was serving up ads promoting notorious sham investment platforms subject to numerous official warnings and easily identified with a simple search. Despite the tech company’s insistence that it had since removed many offending ads and accounts, new ads appeared in recent days using the same techniques and keywords as before. Among the ads published this week were examples misusing the images of Prime Minister Anthony Albanese, singer Guy Sebastian, and those linked to a bogus Salvation Army loan offer. There were also numerous ads promoting Quantum AI, which the consumer watchdog has labelled the “most prolific online investment trading platform scam” affecting Australians. Meta did not respond to questions about the ongoing scam ads by deadline. An image of the PM in a recent fake Salvation Army ad. The scammers behind these types of ads are often seeking to steal people’s personal information. Credit: Meta Ad Library Earlier, the company shared news it had recently taken down 2 million accounts linked to scam centres in South-East Asia and the Middle East. It also confirmed that it had been sharing warnings with Australian Facebook users since October, telling them to “beware of scams using celebrity images to deceive you”. Sergeant Alexander Kazagrandi, with the Australian Federal Police’s Joint Policing Cybercrime Co-ordination Centre, said scam advertising was prolific in Australia and was being used “more and more extensively by organised criminal groups”. He warned that these ads were being used not just to recruit victims but to traffic people into South-East Asian scam call centres by offering them an easy way to make money. “That is essentially the same hook that is being used for Australian victims for investment scam purposes,” Kazagrandi said. A scam ad featuring singer Guy Sebastian. When this screenshot was taken, the ad had been live for 13 hours. Credit: Meta Ad Library Last week, new federal scam laws that are set to force social media platforms, banks and telcos to pay compensation to scam victims were debated in parliament. Some MPs and consumer groups are concerned the bill does not go far enough, arguing it will remain far too difficult for victims to be reimbursed. Kazagrandi said more than 90,000 reports about cybercrime and scams were made to ReportCyber last year, a high proportion of which were investment scams. “On average, an investment scam in Australia will net about $81,000 to the criminal,” he said. Kazagrandi said Australians could expect to hear more about Australian police conducting raids and targeting overseas scam operations in the future, as its ongoing Operation Firestorm investigated cybercriminals based in South-East Asia and Eastern Europe. In July this year, Melbourne woman Anna was feeling stressed and vulnerable when she saw an ad on Facebook falsely claiming to feature Albanese talking about a new investment platform purportedly backed by his government. All Anna had to do – at a time when her husband had left her for another woman, and she was struggling to pay off the mortgage alone as she worked long days as an office administrator – was put in $250. “I just click ... [and] I fill out the application because I was thinking, ‘$250 I can afford’,” said Anna, 61, using a pseudonym. The advertisement was a scam, using a manipulated video of Albanese without his permission, and it connected Anna to ruthless scammers who fleeced her of $30,000 over the coming months, pushing her even further into debt. Anna said the scammers, who claimed to be from England and worked for a company called I2 Trading, tricked her into believing she was making profits on her trading, enough to pay off her mortgage. It wasn’t until she couldn’t withdraw her profits that she realised it was a con. She hadn’t seen the scam warnings previously. “I work full-time, I get home, I don’t watch the news,” she said. The mother of two, who is being assisted by the Consumer Action Law Centre, said the scammer also advised her to approach a digital lender for a loan of $30,000, coaching her to tell them the money was for home renovations. Anna says she is now paying an interest rate of 9.69 per cent on the borrowed money. It means the scam is going to cost her more than $40,000 over seven years. She said she was kept awake with the thought of what she might have done with the money she pays into the loan each month – perhaps a holiday, something for her house, or to fund a more stable life. “I’m struggling,” she said. Monash University Professor Mark Andrejevic, who has researched the types of Facebook ads reaching Australians, said it was pretty clear that Meta was not policing its ads carefully. “It’s easy to find these ads,” he said. “There are a number of indicators, including keywords, the characteristics of the pages that are serving them, and the use of multiple administrators across several countries. When taken together, an automated system should be able to flag this type of advertising easily.” Andrejevic said regulatory change was needed or scams would be a persistent part of the online ad environment. “It doesn’t look like Facebook is making much off of each individual ad buy, but if you imagine how many hundreds of thousands of these are appearing globally, the revenues could be more than just a blip.” Expert tips on how to save, invest and make the most of your money, delivered to your inbox every Sunday. Sign up here for our Real Money newsletter.( MENAFN - KNN India) Patna, Nov 30 (KNN) The Bihar government is taking ambitious steps to position the state as a thriving hub for textiles and leather, aiming to generate large-scale employment and attract significant investments. Senior officials underscore a commitment to fostering an enabling environment through policy support, incentives, and modern infrastructure. A delegation from Bihar's Department of Industries recently visited Tamil Nadu, a leading state in textiles and leather, to study advanced practices and forge collaborations. The team explored Tiruppur, a global textile manufacturing hub, gaining insights into cutting-edge technologies and efficient practices. Alok Ranjan Ghosh, Director of Industries, emphasised the importance of replicating successful models, stating,“The visit has equipped us with critical knowledge to transform Bihar into a textile powerhouse and create employment opportunities.” The delegation also visited Ranipet to observe the zero liquid discharge (ZLD) technology at the Ranitec Common Effluent Treatment Plant. These innovative methods, which recycle 85 per cent of tannery wastewater, hold promise for Bihar's emerging leather sector. Discussions with Selvam, Executive Director of the Council of Leather Exports, further strengthened prospects for the state's leather industry. In its bid to attract investors, the government will host the Bihar Business Connect 2024 in Patna from December 19-20. This event aims to surpass the Rs 50,000 crore investment proposals secured in the 2023 edition, which saw 278 companies signing MoUs worth Rs 50,500 crore. Industries Minister Nitish Mishra expressed optimism about the summit, stating,“We are confident that this year's meet will mark the beginning of a new industrial era in Bihar.” Promotional roadshows across major cities such as Delhi, Mumbai, and Kolkata have already set the stage for this landmark event. Key sectors like food processing, textiles, and tourism are poised for significant investment, further boosting Bihar's industrial growth. By leveraging innovative practices and fostering collaborations, Bihar is charting a path to emerge as a crucial player in India's textile and leather industries. (KNN Bureau) MENAFN30112024000155011030ID1108941696 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.jilibay slot 。

CHICAGO — Newly unsealed court records now link embattled Chicago rapper Lil Durk — already facing murder-for-hire charges in Los Angeles — to the fatal 2022 shooting of an alleged gang leader outside a community center on Chicago’s Far South Side. The warrant application was filed in April 2023 but was not unsealed until Wednesday, in advance of a scheduled Thursday detention hearing in Lil Durk’s murder-for-hire case. Lil Durk — born Devontay Durk Banks — was charged last month with funding a cross-country murder-for-hire plan to exact revenge for the 2020 killing of fellow Chicago rapper King Von in Atlanta. The newly unsealed filing in U.S. District Court in Chicago alleges Banks was behind the Jan. 27, 2022 killing of Stephon Mack , 24, who was shot to death shortly after he exited the Youth Peace Center of Roseland on West 111th Street. At the time of his death, according to the FBI, Mack was the leader of the Smashville faction of the Gangster Disciples. Banks’ brother, Dontay Banks, was shot to death outside a nightclub in south suburban Harvey in 2021. According to the warrant application, another Gangster Disciples faction with ties to Smashville carried out the murder. “Lil Durk was and still is offering money for people to kill those responsible for his brother’s murder, and more specifically, offering to pay money for any Gangster Disciple that is killed,” a federal agent wrote in April 2023. Banks has not been charged in the Chicago investigation, which law enforcement sources told the Tribune is still open and active. Earlier this year, federal prosecutors in Chicago charged two men, Anthony Montgomery-Wilson and Preston Powell, with conspiracy to commit murder-for-hire in Mack’s killing. Banks, though, is not charged in Mack’s death. Federal prosecutors in Los Angeles are expected to point to the shooting as reason to keep Banks in police custody before trial. In probing Mack’s death, federal investigators analyzed jail phone calls, social media postings, firearms purchases, as well as lyrics from Lil Durk’s song “Ahhh Ha,” released about a month after the shooting. The warrant application goes on to say Montgomery-Wilson and Powell “may have exchanged text messages concerning payment for Mack’s murder.” Montgomery-Wilson was arrested on an unrelated charge a few weeks after Mack’s death. A detective with the New Lenox police department then applied for and was granted a warrant to search the contents of his cellphone. Investigators then discovered a two-person text message conversation that mentioned “OTF” — the rap consortium founded by Lil Durk that prosecutors have linked to the alleged murder-for-hire plot in Los Angeles. On Feb. 10, 2022, one of the people in the text conversation asked, “Wassup with otf,” to which the other person responded, “Nothing.” Eight days later, in the same conversation, another text message read, “Did durk gave (sic) u that money.” In a statement last week, Banks’ attorneys blasted the prosecution’s focus on Lil Durk’s music and noted his yearslong record of philanthropy in Chicago. “When you see an artist’s rap lyrics quoted as ‘evidence’ against them, it is a glaring indication that there is no real evidence against that person,” Banks’ attorneys said in a statement to the Tribune. “The real truth is that Durk Banks is a Grammy Award-winning artist, a dedicated father and a loving husband,” Banks’ attorneys added. “Mr. Banks has been intensely committed to giving back to the Chicago community he loves through his Neighborhood Heroes Foundation and has put on more than a dozen charitable events over the last few years. He is looking forward to fighting against these false allegations in court.” In mid-October, federal authorities charged five others in a plot to kill rapper Quando Rondo — born Tyquian Terrel Bowman — in retaliation for the November 2020 shooting death of King Von. Banks is accused of bankrolling the effort to kill Bowman.. Bowman, his sister and his cousin, Saviay’a Robinson, 24, were riding in Bowman’s black Cadillac Escalade near a gas station in West Hollywood in August 2022 when gunmen opened fire, according to the federal charges. Bowman and his sister were not injured, but Robinson was struck multiple times and killed. ©2024 Chicago Tribune. Visit at chicagotribune.com . Distributed by Tribune Content Agency, LLC.SAN DIEGO, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that the Company is scheduled to present at the following upcoming investor conferences. About Capricor Therapeutics Capricor Therapeutics, Inc. (NASDAQ: CAPR) is a biotechnology company dedicated to advancing transformative cell and exosome-based therapeutics to redefine the treatment landscape for rare diseases. At the forefront of our innovation is our lead product candidate, deramiocel (CAP-1002), an allogeneic cardiac-derived cell therapy. Extensive preclinical and clinical studies have shown deramiocel to demonstrate immunomodulatory, antifibrotic, and regenerative actions specifically tailored for dystrophinopathies and heart disease. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Capricor is also harnessing the power of its exosome technology, using its proprietary StealthXTM platform in preclinical development focused on the areas of vaccinology, targeted delivery of oligonucleotides, proteins and small molecule therapeutics to potentially treat and prevent a diverse array of diseases. At Capricor, we stand committed to pushing the boundaries of possibility and forging a path toward transformative treatments for those in need. For more information, visit capricor.com , and follow Capricor on Facebook , Instagram and Twitter . Cautionary Note Regarding Forward-Looking Statements Statements in this press release regarding the efficacy, safety, and intended utilization of Capricor's product candidates; the initiation, conduct, size, timing and results of discovery efforts and clinical trials; the pace of enrollment of clinical trials; plans regarding regulatory filings, future research and clinical trials; regulatory developments involving products, including the ability to obtain regulatory approvals or otherwise bring products to market; manufacturing capabilities; dates for regulatory meetings; statements about our financial outlook; the ability to achieve product milestones and to receive milestone payments from commercial partners; plans regarding current and future collaborative activities and the ownership of commercial rights; potential future agreements; scope, duration, validity and enforceability of intellectual property rights; future revenue streams and projections; expectations with respect to the expected use of proceeds from the recently completed offerings and the anticipated effects of the offerings; and any other statements about Capricor's management team's future expectations, beliefs, goals, plans or prospects constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "believes,” "plans,” "could,” "anticipates,” "expects,” "estimates,” "should,” "target,” "will,” "would” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements. More information about these and other risks that may impact Capricor's business is set forth in Capricor's Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the Securities and Exchange Commission on March 11, 2024, and in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, as filed with the Securities and Exchange Commission on November 14, 2024. All forward-looking statements in this press release are based on information available to Capricor as of the date hereof, and Capricor assumes no obligation to update these forward-looking statements. Capricor has entered into an agreement for the exclusive commercialization and distribution of deramiocel (CAP-1002) for DMD in the United States and Japan with Nippon Shinyaku Co., Ltd. (U.S. subsidiary: NS Pharma, Inc.), subject to regulatory approval. Deramiocel is an Investigational New Drug and is not approved for any indications. None of Capricor's exosome-based candidates have been approved for clinical investigation. For more information, please contact: Capricor Media Contact: Raquel Cona KCSA Strategic Communications [email protected] 212.896.1204 Capricor Company Contact: AJ Bergmann, Chief Financial Officer [email protected] 858.727.1755

Agree Realty Declares Monthly Common and Preferred DividendsPublished 5:20 pm Thursday, December 12, 2024 By Data Skrive Thursday’s college basketball slate features plenty of excitement, including the matchup between the Chattanooga Mocs and the Evansville Purple Aces, and you’ll find our best bets against the spread for seven games here. Watch men’s college basketball, other live sports and more on Fubo. What is Fubo? Fubo is a streaming service that gives you access to your favorite live sports and shows on demand. Use our link to sign up. Bet on this or any men’s college basketball matchup at BetMGM. Not all offers available in all states, please visit BetMGM for the latest promotions for your area. Must be 21+ to gamble, please wager responsibly. If you or someone you know has a gambling problem, contact 1-800-GAMBLER .

Cruise into this holiday season with a non-traditional vacationFirst shots fired to open Sam Brownlee Training Center for the Weld County Sheriff’s OfficeCutting in line? American Airlines’ new boarding tech might stop you at now over 100 airportsHE vice-president of Qatar Red Crescent Society (QRCS) Eng Ebrahim Hashim al-Sada inaugurated the seventh annual forum for foreign missions and offices, which included high-level attendance from the relevant state institutions, alongside the participation of offices and external programs from 14 countries. In his opening speech, HE al-Sada emphasized that "this forum brings QRCS and its partners in both official and non-official organizations working in humanitarian fields together, whether at the leadership level or among field workers, because it allows for exchanging visions and experiences, benefiting from the experience and capabilities of all parties, leading to more integration and a stronger partnership." Additionally, HE al-Sada recalled the successes of QRCS for the current year, noting that 372 projects worth QR390mn have been initiated for the benefit of 4mn people in 2024. Among these projects, over 137 have been approved at the external level, which encompass areas such as health, shelter, water and sanitation, food security, emergency relief, livelihood projects, and education. As part of his remarks, he highlighted the recent achievements of QRCS, including the medical sector receiving the ISO Information Security certificate (ISO27001), which capped Qatar's excellence and leadership in the health sector, which was preceded by Canadian accreditation. Additionally, he mentioned that the General Secretariat of QRCS was awarded the Excellence in Charitable Work Award in Kuwait as well as ISO 9001 certification. Director of QRCS in Gaza, Dr Akram Nassar, spoke in a video recording speech about the damage caused by the war in the strip, which exceeds the loss of human life of over 10% of the population, as well as the displacement of 2mn people living in inhumane conditions. He stated, "The situation here is catastrophic ... Despite the bleak situation, people in the region are still trying to live their lives and look forward to a better future. Humanitarian organizations and institutions, including QRCS, continue to provide their services regardless of all the difficulties and challenges they face. Despite the restrictions faced by relief and medical teams, we remain committed to our humanitarian duties." On this occasion, CEO of the Surgery Department at Sidra Medicine, Dr Mansour Ali, speaking on behalf of the medical and nursing teams, said, "through these convoys, we have been able to provide vital medical care, ranging from lifesaving surgeries to chronic disease treatment, maternal health support to childcare". The opening also witnessed the honouring of several partner entities, in addition to honouring the directors of the offices and missions, as well as recognizing the staff of medical institutions in the country, along with medical and nursing teams from QRCS for their outstanding contributions and efforts in implementing several medical convoys to several countries given that in the years 2023 and 2024, 23 medical convoys were conducted in 13 countries, benefiting 33,500 patients. Over the course of five days, the forum will feature workshops and brainstorming sessions, which will explore strategies for aligning the latest humanitarian and relief practices, including designing emergency plans for the offices, discussing performance indicators and strategies, and incorporating artificial intelligence into humanitarian work. A number of mechanisms will be explored in order to enhance humanitarian efforts on the ground, as well as strengthening partnerships and cooperation with national societies in target countries. In conjunction with the forum's opening, QRCS is showcasing the accomplishments of the offices and missions through an exhibition of artworks depicting the tragedies and human stories experienced by the afflicted. Related Story MSDF, QRCS join hands to bolster family welfare, social development QRCS, UNHCR provide medical services for refugees in Yemen

AP Trending SummaryBrief at 5:06 p.m. EST

Google's new AI tool lets you make chess as weird as you want it - for freeFILE PHOTO: Nov 20, 2024; Piscataway, New Jersey, USA; Rutgers Scarlet Knights guard Ace Bailey (4) attempts to deflect a pass intended for Merrimack Warriors guard Devon Savage (5) during the second half at Jersey Mike's Arena. Vincent Carchietta-Imagn Images/File Photo No. 24 Rutgers will look to continue its torrid start to the season on Sunday afternoon when it visits Kennesaw State in Georgia. The Scarlet Knights' promising five-star recruits, Ace Bailey and Dylan Harper, have been as good as advertised. Bailey has averaged 20 points and 8 rebounds in the two games he's played, while the latter has contributed 19.5 and 5.5, respectively, in his four contests. Bailey collected 23 points and 10 rebounds and Harper added 14 and eight, respectively, to propel Rutgers to a 74-63 victory over Merrimack on Wednesday in Piscataway, N.J. After the contest, Bailey sported a toothy grin that did little to disguise the fun he's having on the court. "We play together, we're all laughing as a team, we're enjoying the game of basketball, how it should be played," Bailey said. "It's fun." Head coach Steve Pikiell might have a different take, at least when considering the game's first 20 minutes against the Warriors anyway. The Scarlet Knights held a seven-point advantage at intermission, but Pikiell wasn't pleased with what he saw on the defensive end. Bailey said he got the message. "You don't play no defense, you ain't gonna play," he said. "Communication-wise, I wouldn't say it was terrible at first, but it was not where it needed to be. It's getting better -- it's still not where it needs to be, but it's improving." It better improve considering Rutgers (4-0) is leaving the Garden State for the first time this season. The Scarlet Knights will exit Georgia after Sunday's game and venture to Las Vegas for the Players Era Festival before visiting Ohio State for the Big Ten opener on Dec. 7. "We need to figure ourselves out, but I am looking forward to the trip," Pikiell said. "I'm gonna try to get these guys to put their phones down for five minutes and really bond as a team. "We wanted to be 4-0 in this stretch, and that's what we are. I'll learn more about our team, but if they keep improving, and they keep staying together, we will have the chance to be very good." Kennesaw State, which is off to a 4-1 start for the third consecutive season, pushed its winning streak to three games on Wednesday with an 84-78 victory over Abilene Christian. Simeon Cottle followed up his 27-point performance in the Owls' 85-67 win over Presbyterian last Saturday with 22 points versus the Wildcats. Cottle sank all 12 of his free throws against the Blue Hose and all 10 versus Abilene Christian to improve to 26-for-26 on the season. "Just constant work being in the gym daily," Cottle said. "We have a little thing called 'free-throw game' at the end of the practice that we do every day. It's consistent reps. By doing that, it's allowed me to be successful with my free throws." Cottle is averaging 18.8 points and 4 assists while fellow guard and two-time Conference USA freshman of the week Adrian Wooley is contributing 15.2 and 3.8, respectively. --Field Level Media REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you. Read 3 articles and stand to win rewards Spin the wheel now

Since their debut in 2013, BTS has released many albums, but all seven members have also debuted as soloists. Which member, in your opinion, has the best title track of all? Vote now! Votes can be cast once every 2 hours until the voting period ends. Why does your choice deserve the top spot? Let us know on our social media, and vote for your favorite could-be couple here: Which K-Drama Couple Would You Like To See Become Dispatch’s New Year Couple? Vote Now! BTS BTS RM’s Inclusion On Organization’s Role Model List Sparks Heated Debate BTS’s V Dethrones Mariah Carey On Billboard Chart BTS Jin’s Comment About Red Velvet Wendy’s Voice Gains Attention Park Myung Soo’s Past “Shade” About HYBE Sparks Major Backlash See more BTS

Graybar Names Bryant L. Summers District Vice President in St. LouisPromotion Affirms Company's Commitment to Galvanize New Era of Tech-Driven Real Estate Investment NEW YORK , Dec. 12, 2024 /PRNewswire/ -- Underscoring its commitment to revolutionize investment strategies by leveraging advanced technologies to drive investor value, real estate investment firm AWH Partners announces the promotion of Devashish (Dev) Sharma to director of analytics. Sharma, who has been with the New York -based firm since July 2023 , has played a pivotal role in enhancing returns for investors by strengthening the integration of technology and data analytics in his previous role in asset management. In this new position, he will leverage the firm's data assets to create insights that sharpen acquisition strategies, improve asset performance, and strengthen overall decision-making and corporate governance, ultimately driving superior outcomes for stakeholders. In leading this newly created role, Sharma will focus on enhancing AWH Partners' cross-functional data ecosystem and optimizing technology-enabled processes to deliver actionable investment insights, streamline analysis, automate recurring tasks, and identify market opportunities ahead of industry trends. By developing business intelligence tools and mechanisms, he will ensure the firm's leadership and continuity in hospitality real estate, delivering enhanced transparency and scalability of tech-driven initiatives to foster sustainable growth and maximize investor returns. With dual master's degrees in business administration and hospitality management from Cornell University , Sharma has 13 years' experience across investment banking, real estate financing, hotel acquisition and hotel asset management. Before relocating to the U.S. for his graduate studies, Sharma was the investment manager at SAMHI Hotels, which specializes in hotel investments in India , and an associate investment manager at Piramal Fund Management, one of the first firms to enter real estate fund management in India . His global expertise in real estate financing and operational excellence has directly contributed to the success of the firm's high-value investment portfolios. "Dev brings a truly exceptional background to this new role with his experience in real estate financing and data analytics, as well as earning advanced degrees in business and hospitality from one of this country's premier Ivy League universities. Since joining AWH, he has demonstrated dedication and passion for helping the firm realize the next level of data-driven decision-making," said Chad Cooley , co-founder and managing partner of AWH Partners. "His work has strengthened our ability to deliver consistent value to our investors, helping us stand out in an increasingly competitive market." AWH Partners has made substantial investments in technology to identify and acquire differentiated investment opportunities in a highly competitive marketplace. This position underscores the firm's strategic focus on combining innovation and expertise to generate superior investor outcomes. By empowering its team with leadership opportunities, AWH Partners fosters an environment where talent thrives, furthering its goal of shaping the future of real estate investment. Sharma's leadership will continue to advance the firm's mission to deliver sustainable growth and performance across its portfolio. A native of India , Sharma is a chartered accountant and earned his bachelor's degree in finance from Sri Venkateswara College at the University of Delhi in 2009. Sharma's global perspective and track record of integrating analytics into investment strategies position him as a key player in advancing AWH Partners' investor-centric vision. "My goal is to further integrate analytics into every aspect of our investment process to ensure we are at the forefront of data and technology use in real estate investment worldwide," he said. About AWH Partners: AWH Partners (AWH) is a leading national platform for hotel real estate investment, management and development. Privately held, it was founded in 2010 by alumni of The Blackstone Group and The Related Companies. The firm partners with marquee institutional investors, family offices, and high-net-worth individuals around the world. Its portfolio includes properties from renowned brands, including the Marriott and Hilton corporations, as well as independently branded assets. View original content to download multimedia: https://www.prnewswire.com/news-releases/awh-partners-promotes-dev-sharma-as-director-of-analytics-302330763.html SOURCE AWH Partners